Vontobel Holding’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Buy
916,169
+209,524
+30% +$5.48M 0.07% 222
2026
Q1
$19.8M Sell
706,645
-194,932
-22% -$5.19M 0.07% 208
2025
Q4
$22.4M Buy
901,577
+69,949
+8% +$1.76M 0.07% 208
2025
Q3
$21.2M Buy
831,628
+95,393
+13% +$2.35M 0.06% 192
2025
Q2
$17.8M Buy
736,235
+14,808
+2% +$345K 0.06% 198
2025
Q1
$18.3M Buy
721,427
+29,825
+4% +$780K 0.07% 174
2024
Q4
$18.3M Buy
691,602
+139,894
+25% +$3.79M 0.06% 166
2024
Q3
$16M Buy
551,708
+57,013
+12% +$1.66M 0.05% 189
2024
Q2
$13.8M Buy
494,695
+34,333
+7% +$945K 0.05% 190
2024
Q1
$12.8M Buy
460,362
+17,055
+4% +$473K 0.1% 182
2023
Q4
$12.8M Sell
443,307
-108,914
-20% -$3.29M 0.11% 180
2023
Q3
$18.3M Sell
552,221
-65,064
-11% -$2.3M 0.17% 136
2023
Q2
$22.6M Buy
617,285
+45,115
+8% +$1.76M 0.2% 129
2023
Q1
$23.3M Sell
572,170
-97,044
-15% -$4.19M 0.22% 116
2022
Q4
$34M Buy
669,214
+71,498
+12% +$3.43M 0.34% 71
2022
Q3
$26.2M Buy
597,716
+178,509
+43% +$8.67M 0.31% 87
2022
Q2
$21.4M Buy
419,207
+35,603
+9% +$1.81M 0.23% 108
2022
Q1
$20.1M Sell
383,604
-19,774
-5% -$1.03M 0.17% 126
2021
Q4
$23.6M Sell
403,378
-160,351
-28% -$7.94M 0.2% 114
2021
Q3
$24.2M Sell
563,729
-329,610
-37% -$14.6M 0.21% 99
2021
Q2
$34.9M Sell
893,339
-350,528
-28% -$13.6M 0.3% 61
2021
Q1
$45.1M Buy
1,243,867
+273,363
+28% +$9.71M 0.33% 40
2020
Q4
$33.8M Buy
+970,504
New +$35.6M 0.22% 65

Other funds holding PFE

Vontobel Holding's PFE Position: Q2 2026 in Review

Vontobel Holding increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $5.48M and bringing the position to 916,169 shares worth $22.1M. The position accounts for 0.07% of the portfolio, ranked #222.

Vontobel Holding first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $45.1M in Q1 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vontobel Holding held 916,169 shares of Pfizer worth $22.1M as of Q2 2026.
  • Vontobel Holding bought 209,524 Pfizer shares in Q2 2026, an estimated $5.48M.
  • Pfizer made up 0.07% of Vontobel Holding's portfolio in Q2 2026, its #222 holding.
  • Vontobel Holding first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Pfizer position peaked at $45.1M in Q1 2021.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.